Cargando…

The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China

BACKGROUND: A nationwide ban on family/replacement donation (FRD) went into effect on April 1, 2018 in China. To date, no reports relevant to the trend of plateletpheresis donations before and after a nationwide ban on FRD were found. METHODS: We used two independent full samples, consisting of 135,...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jinyan, Zhou, Guoli, Fu, Xuemei, Li, Shijie, Li, Ying, Kang, Jianxun, Chen, Huiyou, Zhou, Liqiao, Fu, Yongshui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082857/
https://www.ncbi.nlm.nih.gov/pubmed/33926409
http://dx.doi.org/10.1186/s12889-021-10819-4
_version_ 1783685918062804992
author Chen, Jinyan
Zhou, Guoli
Fu, Xuemei
Li, Shijie
Li, Ying
Kang, Jianxun
Chen, Huiyou
Zhou, Liqiao
Fu, Yongshui
author_facet Chen, Jinyan
Zhou, Guoli
Fu, Xuemei
Li, Shijie
Li, Ying
Kang, Jianxun
Chen, Huiyou
Zhou, Liqiao
Fu, Yongshui
author_sort Chen, Jinyan
collection PubMed
description BACKGROUND: A nationwide ban on family/replacement donation (FRD) went into effect on April 1, 2018 in China. To date, no reports relevant to the trend of plateletpheresis donations before and after a nationwide ban on FRD were found. METHODS: We used two independent full samples, consisting of 135,851 and 82,129 plateletpheresis donors from Guangzhou and Chengdu between October 2012 and September 2019, respectively. A pseudo-panel data approach was applied by grouping three time-invariant covariates – gender, blood donation history, and birth year across 14 cross-sections (a 6-month interval each) to form a total of 24 cohort groups (14 × 24 = 336 cohorts, i.e., cells) with each having common covariates. The outcome was average apheresis platelet units per donor in each cell. We performed a two-piecewise linear mixed model with the cross-section (i.e., time) just right before the ban as a time breakpoint (i.e., 11th cross-section) to examine the trend of outcome with the adjustment of three time-invariant covariates. We removed the FRDs in each of the first 11 cross-sections to detect its possible influence on the trend. RESULTS: The final model for the samples from Guangzhou presented a two-piecewise linear trend of the outcome over time with a horizontal line to the left of the breakpoint (β(timeBefore11) = 0.0111, p = 0.0976) and a significantly positive linear trend to the right (β(timeAfter11) = 0.0404, p < 0.0001). The male donors and the donors with plateletpheresis donation history had an increased baseline outcome and a significant outcome change over time after the ban. Such a two-piecewise linear trend pattern can be replicated using the samples from Chengdu with some minor variations. Removing the FRD before the ban can change the pattern. CONCLUSION: The significant increase of the average apheresis platelet units per donor over time after the FRD ban may be related to the implement of the FRD ban and the improved donation behavior of male donors and/or donors with platelet donation history after the ban. Our findings may potentially motivate the policymakers in other countries where the FRD for plateletpheresis donation is still legitimate to phase out their FRD strategy and ultimately achieve 100% voluntary plateletpheresis donation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-10819-4.
format Online
Article
Text
id pubmed-8082857
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-80828572021-04-29 The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China Chen, Jinyan Zhou, Guoli Fu, Xuemei Li, Shijie Li, Ying Kang, Jianxun Chen, Huiyou Zhou, Liqiao Fu, Yongshui BMC Public Health Research BACKGROUND: A nationwide ban on family/replacement donation (FRD) went into effect on April 1, 2018 in China. To date, no reports relevant to the trend of plateletpheresis donations before and after a nationwide ban on FRD were found. METHODS: We used two independent full samples, consisting of 135,851 and 82,129 plateletpheresis donors from Guangzhou and Chengdu between October 2012 and September 2019, respectively. A pseudo-panel data approach was applied by grouping three time-invariant covariates – gender, blood donation history, and birth year across 14 cross-sections (a 6-month interval each) to form a total of 24 cohort groups (14 × 24 = 336 cohorts, i.e., cells) with each having common covariates. The outcome was average apheresis platelet units per donor in each cell. We performed a two-piecewise linear mixed model with the cross-section (i.e., time) just right before the ban as a time breakpoint (i.e., 11th cross-section) to examine the trend of outcome with the adjustment of three time-invariant covariates. We removed the FRDs in each of the first 11 cross-sections to detect its possible influence on the trend. RESULTS: The final model for the samples from Guangzhou presented a two-piecewise linear trend of the outcome over time with a horizontal line to the left of the breakpoint (β(timeBefore11) = 0.0111, p = 0.0976) and a significantly positive linear trend to the right (β(timeAfter11) = 0.0404, p < 0.0001). The male donors and the donors with plateletpheresis donation history had an increased baseline outcome and a significant outcome change over time after the ban. Such a two-piecewise linear trend pattern can be replicated using the samples from Chengdu with some minor variations. Removing the FRD before the ban can change the pattern. CONCLUSION: The significant increase of the average apheresis platelet units per donor over time after the FRD ban may be related to the implement of the FRD ban and the improved donation behavior of male donors and/or donors with platelet donation history after the ban. Our findings may potentially motivate the policymakers in other countries where the FRD for plateletpheresis donation is still legitimate to phase out their FRD strategy and ultimately achieve 100% voluntary plateletpheresis donation. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12889-021-10819-4. BioMed Central 2021-04-29 /pmc/articles/PMC8082857/ /pubmed/33926409 http://dx.doi.org/10.1186/s12889-021-10819-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Chen, Jinyan
Zhou, Guoli
Fu, Xuemei
Li, Shijie
Li, Ying
Kang, Jianxun
Chen, Huiyou
Zhou, Liqiao
Fu, Yongshui
The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China
title The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China
title_full The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China
title_fullStr The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China
title_full_unstemmed The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China
title_short The apheresis platelet donation was increased after a nationwide ban on family/replacement donation in China
title_sort apheresis platelet donation was increased after a nationwide ban on family/replacement donation in china
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8082857/
https://www.ncbi.nlm.nih.gov/pubmed/33926409
http://dx.doi.org/10.1186/s12889-021-10819-4
work_keys_str_mv AT chenjinyan theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT zhouguoli theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT fuxuemei theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT lishijie theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT liying theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT kangjianxun theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT chenhuiyou theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT zhouliqiao theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT fuyongshui theapheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT chenjinyan apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT zhouguoli apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT fuxuemei apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT lishijie apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT liying apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT kangjianxun apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT chenhuiyou apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT zhouliqiao apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina
AT fuyongshui apheresisplateletdonationwasincreasedafteranationwidebanonfamilyreplacementdonationinchina